Prescient Therapeutics Limited (AU:PTX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Prescient Therapeutics Limited announced the cessation of 1 million options due to unmet conditions, effective from February 19, 2024. The company provided this update in an official statement on April 5, 2024, detailing the lapse of options that were set to expire in December 2025.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.